Skip to main content

1 Result(s)

within Javier Cortés Remove this filter Biomedicine, general Remove this filter Epidemiology Remove this filter

and

  1. No Access

    Article

    PI3K activation promotes resistance to eribulin in HER2-negative breast cancer

    Eribulin is a microtubule-targeting agent approved for the treatment of advanced or metastatic breast cancer (BC) previously treated with anthracycline- and taxane-based regimens. PIK3CA mutation is associated wi...

    Albert Gris-Oliver, Yasir H. Ibrahim, Martín A. Rivas… in British Journal of Cancer (2021)